Chances are, you know someone who has cancer.
Просмотров: 257 CBS 4 News Rio Grande Valley
On Wednesday, November 13, 2013, from 6:00 to 7:30 PM ET, watch our experts discuss genes that increase the risk for cancer — with a focus on breast and ovarian cancers — as well as genetic testing, counseling, and decisions about treatment. WCBS-TV medical reporter Dr. Max Gomez will moderate the discussion.
Просмотров: 766 Memorial Sloan Kettering
Ambry Genetics is pleased to offer BRCA1 and BRCA2 analysis as part of our comprehensive cancer-testing menu. BRCA1/2 will be offered as part of a high-risk hereditary breast cancer Test - BRCAplus, detects mutations in six clinically actionable genes (BRCA1, BRCA2, CDH1, PTEN, STK11 and TP53) implicated in breast cancer, using next-generation sequencing (NGS) in addition to a stand alone test comprised of gene sequence and deletion/duplication analysis and other NGS cancer tests like BreastNext. Learn more about this test at: http://www.ambrygen.com/tests/brca1-and-brca2
Просмотров: 235354 Ambry Genetics
"Targeted Capture and Massively Parallel Sequencing for Genetic Testing of Breast and Ovarian Cancer" Tomas Walsh, Research Asst. Professor with UW Medicine, describes the development of a comprehensive genetic test for inherited breast and ovarian cancer. The assay, called BROCA, uses DNA capture and next generation sequencing technology and is highly sensitive for identifying mutations in a panel of 21 tumor suppressor genes, including BRCA1, BRCA2, and other genes known to cause inherited breast or ovarian carcinoma. In the present study, BROCA is applied to analyze the germline DNA from 360 women undergoing surgery for primary ovarian, peritoneal, or fallopian tube carcinoma at the University of Washington.
Просмотров: 939 UW Video
To learn more visit: http://www.komen-houston.org/
Просмотров: 847 KOMENHOUSTON
Four siblings get tested for the breast and ovarian cancer gene. Overlook Medical Center physicians Bonni Guerin, MD, director, Breast Cancer Prevention Program, and Darius Adams, MD, director, Personalized Genomic Medicine Program, discuss BRCA testing and options. For more information on the Breast Cancer Prevention Program at Overlook Medical Center, visit http://www.atlantichealth.org/simon/our+services/cancer+type/breast/learn/breast+cancer+prevention+programs/breast+cancer+prevention+program+at+overlook+hospital.
Просмотров: 644 OverlookMedicalNJ
Visit http://bit.ly/MyMenoMag for more information on menopause. Dr. Mache Seibel interviews Dr. Noah Kauff from Memorial Sloan-Kettering Cancer Center at the May 2013 ACOG Annual Meeting in New Orleans. Find out if you need cancer screening for an inherited type of breast cancer, ovarian cancer, uterine cancer, colon cancer. As the editor of "My Menopause™ Magazine" (which you can find on the Apple Newsstand), Dr. Mache Seibel http://www.doctorseibel.com/contact-us/ is one of the leading voices in medicine, guiding women on how to navigate menopause and what can be a very confusing time in a woman's life and health. Dr. Seibel is repeatedly selected by his peers as one of the Best Doctors in America. He is a true pioneer in women's health and a Member of the Harvard Medical School faculty for 20 years.
Просмотров: 454 Mache Seibel, MD
http://www.mdanderson.org/education-and-research/resources-for-professionals/professional-educational-resources/professional-oncology-education/hboc/index.html Hereditary Breast and Ovarian Cancer syndrome (HBOC) is an inherited tendency to develop breast, ovarian, and other cancers, and at a younger age than usual. The majority of HBOC is due to a mutation in either the BRCA1 or BRCA2 genes. Dr. Banu Arun, co-medical director and clinical cancer genetics professor, describes new free continuing medical education courses that covers information on a woman's risk of developing breast cancer, screening, chemoprevention, genetic testing for breast cancer, and management of disease.
Просмотров: 394 MD Anderson Cancer Center
Angelina Jolie has made the surprising announcement that she's undergone a double mastectomy. Doctors discovered she carries a gene mutation that dramatically increases her chances of getting breast cancer. So what is this gene, and how do women go about testing for it? Trace takes a look. Read More: Angelina Jolie: I had Double Mastectomy http://news.discovery.com/human/genetics/angelina-jolie-had-double-mastectomy-130514.htm "Angelina Jolie revealed Tuesday that she has undergone a preventive double mastectomy to reduce her risk of contracting breast cancer." My Medical Choice http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html "MY MOTHER fought cancer for almost a decade and died at 56." What's the Gene That Led to Angelina Jolie's Double Mastectomy? http://www.cnn.com/2013/05/14/health/jolie-what-is-brca/index.html "Angelina Jolie's stunning announcement that she had a preventive double mastectomy raised both awareness and questions about the gene that led to her decision -- BRCA1." Why More Women are Choosing Double Mastectomies http://www.cnn.com/2013/03/13/health/double-mastectomy-rates-up/index.html "Ten months ago, Vanessa Thiemann lay in bed unable to sleep." Jolie's Cancer Risk Shared by Others with Genetic Flaw http://www.usatoday.com/story/news/nation/2013/05/14/jolie-breast-cancer-gene/2157649/ "Angelina Jolie revealed that she had a double mastectomy. Her genetic profile and family history added up to a very high risk of breast cancer." BRCA Gene Test for Breast Cancer http://www.mayoclinic.com/health/brca-gene-test/MY00322 "The BRCA gene test is a blood test that uses DNA analysis to identify harmful changes (mutations) in either one of the two breast cancer susceptibility genes — BRCA1 and BRCA2." Not Every Woman Should Get the BRCA Gene Test, U.S. Task Force Says http://articles.latimes.com/2013/apr/01/news/la-heb-brca-breast-ovarian-cancer-testing-20130401 "Certain mutations in the BRCA1 and BRCA2 genes can increase a woman's chances of developing breast cancer or ovarian cancer dramatically." Explaining Angelina Jolie's Double Mastectomy: What It Is, How it's Done and Why it Helps Prevent Breast Cancer http://arts.nationalpost.com/2013/05/14/explaining-angelina-jolies-double-mastectomy-what-it-is-how-its-done-and-why-it-helps-prevent-breast-cancer/ "Oscar-winning actress Angelina Jolie announced on Tuesday that she had a preventive mastectomy after learning she had a gene that significantly raised her risk of breast cancer. Here's a crash course in the procedure Jolie had and why." ____________________ DNews is dedicated to satisfying your curiosity and to bringing you mind-bending stories & perspectives you won't find anywhere else! New videos twice daily. Watch More http://www.youtube.com/dnewschannel Subscribe http://www.youtube.com/channel/UCzWQYUVCpZqtN93H8RR44Qw?sub_confirmation=1 DNews Twitter http://twitter.com/dnews Anthony Carboni Twitter http://twitter.com/acarboni Laci Green Twitter http://twitter.com/gogreen18 Trace Dominguez Twitter http://twitter.com/trace501 DNews Facebook http://facebook.com/dnews DNews Google+ http://gplus.to/dnews DNews Website http://discoverynews.com
Просмотров: 49395 Seeker
Actress Angelina Jolie has sparked a national conversation after opting to undergo a preventative double mastectomy when she tested positive for the breast cancer gene, BRCA1. Jolie's family history combined with her test results put her at high risk for breast and ovarian cancer, according to news reports. Jolie's choice to undergo a preventative double mastectomy reduced her risk of developing breast cancer from 87% to 5%. Dr. Jennifer Klemp, Ph.D, MPH, Director of the Breast Cancer Survivorship Center at The University of Kansas Cancer Center, explains what Jolie and many women go through when assessing the risks of genetic testing. For more information, visit http://www.kucancercenter.org/cancer-information/specialties-and-treatment/breast-cancer/survivor-center
Просмотров: 5232 The University of Kansas Cancer Center
Did you know that people of Ashkenazi Jewish ancestry have a 1 in 40 chance of carrying a BRCA gene mutation, putting them increased risk for breast and ovarian cancer? Basser Research Center patients discuss their BRCA journeys.
Просмотров: 629 Penn Medicine
What is ovarian cancer, who is at risk and what can you do about it? Sydney Cancer Genetics is a specialised medical service supporting individuals and families concerned about cancer. Our services include: assessment of familial risk genetic testing cancer prevention information cancer risk management family planning support
Просмотров: 1546 SydneyCancerGenetics
With so much attention paid to cancer risk, it turns out for some people, cancer is in their genes - which is why many people are turning to genetic counselors. "We do a family tree and if there's a lot of cancers in their family and they meet the criteria, I explain to them what the genetic testing is, what it can do, what can we find out. And then they decide whether or not they want to pursue testing," says Mary Ann Orlang, genetic counselor with Lee Memorial Health System. As researchers continue unlocking clues in the DNA, genetic counselors are now looking for markers that reveal risk. Notable examples are the BRCA mutations, which can be tested through the Regional Cancer Center. "Yes, we can either do a blood sample or we can do saliva. This kit happens to have mouthwash with it to help collect the buckle cells or cheek cells," says Orlang. These markers could make the difference between life and death. Genetic testing is giving many women a roadmap for care. If they have BRCA mutations, many will have surgery to remove their breasts, ovaries and for the most part, their risk. "In your lifetime you have 60-90% chance of developing breast cancer. And in terms of ovarian cancer the numbers are somewhere around 30-35%. It's certainly significant when you think about the average risk for a woman developing breast cancer would be somewhere around 1.5% in their lifetime," says Dr. Frank Rodriguez, oncologist on Lee Memorial Health System's medical staff. Based on successes in breast, ovarian, prostate and colorectal cancers, there is more movement in identifying cancer-linked DNA. "There are so many genes and so many proteins and the way that your genetic code has so many moving parts, there's plenty of room for people who want to do research," says Dr. Rodriguez. Meaning someday each one of us may know our individual cancer risks. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 189 Lee Health
Gynecologist Oncologist Dr. Mike Janicek talks about the importance of genetic testing, and explains why it is a moral issue. If a woman is diagnosed with breast cancer and is the only living relative with breast cancer, it her duty to have a BRCA test if she has a daughter, he says. Watch this video to learn more about testing for BRCA gene mutations and why it's important. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/user/drjayharness VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS http://www.breastcanceranswers.com/video-categories/ SUBMIT A QUESTION http://www.breastcanceranswers.com/ask DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers Twitter: https://twitter.com/BreastCancerDr ______ Disclaimer: This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
Просмотров: 3126 Breast Cancer Answers®
New development in Angelina Jolie's decision to have a double mastectomy -- she has now opted to have her ovaries removed. Dr. James Stewart, Chief of Hematology/Oncology at Baystate Medical Center, shares his insight into the role genetics plays in breast cancer risk and what you should do if your test is positive.
Просмотров: 152 BAYSTATEHEALTH
Просмотров: 72 Genetalk
Actress Angelina Jolie stunned the world with her Op-Ed in The New York Times, in which she shared her very private decision to have a preventive double mastectomy after testing positive for the BRCA1 gene mutation. But for Jolie, and many others, getting genetic testing and taking action may offer control and comfort. Judy Garber, MD, MPH, is director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, and one of the leaders of the Institute's Susan F. Smith Center for Women's Cancers. She talks about the BRCA test, family history and cancer risk, and preventive options for breast and ovarian cancer. Learn more about the Cancer Genetics and Prevention Program at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Cancer-Genetics-and-Prevention-Program.aspx#1 Transcription: This test is a blood test, so it’s a pretty easy test to have. Almost everyone who recommends this test believes it should be performed with genetic counseling, so that women understand when they have their testing what they’re doing, what kind of information they’re going to receive, and what the implications of a positive or negative test might be. The question is really is, “Do you have the kind of family history or personal history that makes it possible that a BRCA1 or BRCA2 or other mutation might be present?” If you were found to have high risk of breast and ovarian cancer (and if you read Angelina’s piece, she’s very clear that the risks are much higher than the general population), would you be willing to do the kinds of things that would be recommended? They include much more careful monitoring—mammograms and breast MRIs and examinations on a regular basis, trying to find these cancers early for breast cancer, considering surgery to reduce risk, considering other strategies. Actually removing the ovaries can lower breast cancer risk, and since we have no good early detection for ovarian cancer, we often have to recommend women have their ovaries and fallopian tubes removed. It depends where in your life you are when you learn that you have this risk. Have you had your children yet? Have you even had a partner yet? Have you finished your family and you're ready to consider this? Have you seen cancer up close and you just don’t want to go there? And what are you willing to do? I’m seeing most people these days contact their primary care physician or their gynecologist. They're either tested by those physicians or they're referred to a center that does testing. If they’re positive, we hope they’ll all be seen in specialized centers, because in this area we have them, and we hope that we make women’s lives better, even if they have to go with a difficult diagnosis.
Просмотров: 4626 Dana-Farber Cancer Institute
Dr. May Lynn Quan speaks with health specialist Heather Yourex on genetic testing, and the benefits it could hold for those with a family history of breast and ovarian cancer. Dr. Quan is the lead for the Calgary Breast Health Program, and is a breast surgeon.
Просмотров: 687 Global News
The Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine presents "Sara's Story: Hereditary Breast and Ovarian Cancer." Sara, a patient, shares her story about finding out she carries a BRCA gene mutation. Dr. Susan Klugman, director of reproductive genetics at Montefiore Medical Center/Einstein provides insight on the options for BRCA gene mutation carriers. Visit www.myjewishgenetichealth.com to access the full Hereditary Breast and Ovarian Cancer lesson.
Просмотров: 106 Program for Jewish Genetic Health
War Memorial Hospital Community Education Series Dr. Paula Rechner Breast Cancer and Genetic Testing October 17, 2013 at Bayliss Public Library, a member of Superior District Library, Sault Sainte Marie, Michigan
Просмотров: 561 Bayliss Public Library, a Superior District Library
Angelina Jolie is making headlines after announcing Tuesday that she had a preventive double mastectomy after testing positive for the BRCA mutation, a gene that increases a woman's risk of breast and ovarian cancers.
Просмотров: 158 WLWT
A research study led by physicians at Allegheny General Hospital found that a certain genetic variation will predict whether women at high risk for breast cancer will respond to the preventive drugs tamoxifen and raloxifene. The findings from the study of more than 600 high-risk women are a step forward toward a time when all cancer care is tailored to a patient's individual genetics, said Dr. Thomas Julian, Director of Breast Surgical Oncology at Allegheny General, in an interview with KDKA-TV. To learn more about the treatment of breast cancer, visit http://www.wpahs.org/specialties/cancer-institute/breast-cancer
Просмотров: 222 Allegheny Health Network
The Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine presents "Sara's Story: Hereditary Breast and Ovarian Cancer." Sara, a patient, shares her story about finding out she carries a BRCA gene mutation. Dr. Susan Klugman, director of reproductive genetics at Montefiore Medical Center/Einstein provides insight on the options for BRCA gene mutation carriers. Visit www.genesights.com to access the full Hereditary Breast and Ovarian Cancer lesson.
Просмотров: 671 Yeshiva University
Are you at risk of developing breast cancer? Learn if you should take the Breast Cancer (BRCA) Gene test. Click the link below to ask Dr. Christine Horner a health question. http://www.ivlproducts.com/pages/Forum-Signup/?utm_campaign=Youtube&utm_medium=Social&utm_source=Youtube
Просмотров: 2594 Independent Vital Life, LLC
Board Certified Genetic Counselor Brandy Freschi discusses Angelina Jolie, the BRCA genes and genetic testing. For more information on BRCA and other hereditary breast and ovarian cancer syndromes: FORCE (Facing Our Risk of Cancer Empowered) FacingOurRisk.org or RenoCancerGenetics.com Audio provided by Alice 96.5
Просмотров: 258 Renown Health
For more information visit: http://www.komen-houston.org/
Просмотров: 166 KOMENHOUSTON
ESCONDIDO - May 27, 2013 - Specialists from the Palomar Medical Center held a news conference Monday afternoon to discuss early breast and ovarian cancer detection and the BRCA genes. These are the same genes that Angelina Jolie was concerned about when she decided to undergo a double mastectomy. Jolie's aunt, Debbie Martin, had the same defective gene as Jolie and died on Sunday after battling breast cancer. The family wants to raise awareness. The above information has not been completely verified. It may be based on several sources and is intended as preliminary information only. Address: 2185 Citracado Parkway, Escondido Interviews: Elizabeth Revesz, M.D., Breast Surgeon, Cheryl Cina, MS, LCGC, Certified Genetic Counselor (Both from Jean McLaughlin Women's Center For Health & Healing) http://www.sandiegonewsvideo.com/
Просмотров: 1034 San Diego News Video
Angelina Jolie's decision to go public with genetic testing and subsequent decision to have a double mastectomy resonated with Medical City patients. Channel 11 highlighted Medical City Breast Center medical director Dr. Alison Laidley, as well as one of her patients. This story aired in its entirety in May of 2013 on CBS 11 in Dallas.
Просмотров: 819 Medical City Dallas
Talia Donenberg, MS, CGC sits down with us to discuss the past, present and future of hereditary cancer testing as well as her experiences in the field. Learn more about genetic testing at http://ww.ambrygen.com/
Просмотров: 540 Ambry Genetics
Cancer struck close to Leslie Anderson's heart. "I unfortunately lost my mother to breast cancer when I turned 18," says Leslie Anderson. And three years ago her sister was diagnosed with ovarian cancer. The two occurrences, years apart, triggered something in Anderson. "I knew in the back of my mind that we would be excellent candidates to be tested for the BRCA gene. And out of the four sisters I have, three of us came back positive for BRCA 1," says Anderson. "BRCA gene is an inherited gene line mutation that puts people at an elevated risk for breast cancer. Basically because the protein their body makes does not repair their DNA properly," says Dr. Lea Blackwell, surgical breast oncologist on Lee Memorial Health System's medical staff. Knowledge is power. In this case, genetic advances are helping women find out if they are pre-disposed to breast and ovarian cancers. Both are linked to this BRCA gene. The information puts them in the driver's seat. "You can act on that information and try to prevent breast cancer. And what's recommended is to have a prophylactic mastectomy. And then they also recommend that you have bilateral ovarian removal," says Dr. Blackwell. It wasn't a tough choice for Anderson. It was the only choice. She had both breasts and both ovaries removed. "The research that they have done has shown that it reduces our risk from 90% to less than 2%. Having seen my mother go thru that, I just really wanted to take that off the table," says Anderson. Only a fraction of women have this mutation- it's more common in women with specific, aggressive forms of disease. "Women with triple negative breast cancer, and people under the age of 40 with breast cancer," says Dr. Blackwell. Anderson seized the chance her mother never had- and took the weight off her chest. "Almost like an anchor on your chest, I feel that's totally gone," says Anderson. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 224 Lee Health
Newton-Wellesley Hospital oncologist, Caroline Block, MD, discusses when BRCA1 and BRCA2 testing is recommended. BRCA1 and BRCA2 gene mutations are linked to breast and ovarian cancers. By testing for these mutations, people can learn if their family history of breast cancer is due to an inherited gene mutation. Physicians may recommend BRCA1 and BRCA2 genetic testing for patients diagnosed with breast cancer, who are diagnosed at a young age, who have a family history of breast and other related cancers, or are of Ashkenazi Jewish descent.
Просмотров: 403 Newton-Wellesley Hospital
OvaNext is a next generation (next-gen) sequencing panel that simultaneously analyzes 23 genes that contribute to increased risk for breast, ovarian and/or uterine cancers. Ambry utilizes next generation sequencing to offer a comprehensive genetic testing panel for hereditary gynecologic cancers (cancer of the breast, ovary and/or uterus), including BRCA1 and BRCA2. Genes on this panel include ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, and TP53. Full gene sequencing and analysis of all coding domains plus at least 5 bases into the 5' and 3' ends of all the introns and untranslated regions (5'UTR and 3'UTR) is performed for 22 of the 23 genes (excluding EPCAM). Gross deletion/duplication analysis is performed for all 23 genes. Specific-site analysis is available for individual gene mutations known to be in the family. Learn more about the test at: http://www.ambrygen.com/tests/ovanext
Просмотров: 1307 Ambry Genetics
The recent wave of publicity about Angelina Jolie's decision to have a preemptive double mastectomy after discovering she had a mutated BRCA1 gene that is know to raise the risks of breast and ovarian cancers, has prompted some debate on whether she made the right decision. Although most cancers are thought of as sporadic events, approximately 10 percent are hereditary. These hereditary cancers are due to specific inherited factors or genes that cause an increase in susceptibility to develop certain cancers. Families can pass on a gene from generation to generation, which increases the risk of these cancers to develop at a young age. In Angelina Jolie's case her mother died at a young age of ovarian cancer. St. Luke's Mountain States Tumor Institute has an active genetic testing and genetic counseling program. Heather Hussey, a genetic counselor with St. Luke' MSTI, talks about Angelina Jolie's decision and the benefits and challenges of deciding to undergo genetic testing.
Просмотров: 361 St. Luke's Health System
Cancer Genetic Counselor, Kayla Czape, MS, CGC, provides an introduction to the genetic counseling process, discusses the breast cancer genetic testing options now available, and talks about important details regarding insurance coverage for genetic testing and medical management options for individuals found to carry a gene mutation. Learn more at http://www.ambrygen.com/
Просмотров: 1324 Ambry Genetics
Breast & Ovarian Cancer: The Mother-Daughter Connection
Просмотров: Memorial Hermann
http://www.dailyrx.com/preventive-mastectomies-reduce-breast-and-ovarian-cancer-risks-are-personal-choices http://www.dailyrx.com/conditions/breast-cancer-female Preventative mastectomies have been all over the news lately. But is it the right choice for you? Mega-star Angelina Jolie announced in the New York Times that she had opted to remove both breasts in a double mastectomy in order to reduce her risks of developing both breast and ovarian cancer. But is this the right decision for other women? There are two BRCA genes: BRCA1 and BRCA2. When not working properly, these genes promote the growth of cancer cells. Women who have changes, or mutations, in one or both of these genes have a greater risk of both breast cancer and ovarian cancer. If you have a family history of breast or ovarian cancer, you will probably want to talk with your doctor about genetic testing. Overall, experts agree that surgery is always the woman's choice. Preventative double mastectomies do reduce the risk of breast cancer but this type of surgery is only indicated for women who carry the mutation. Talk to your oncologist about genetic testing and your treatment options. For dailyRx TV, I'm Erin White.
Просмотров: 69 dailyRx
The National Ovarian Cancer Coalition and Sharsheret held a free webinar, Ovarian Cancer Genetics 101, focused on genetic counseling, genetic testing and the implications for those who undergo genetic counseling and testing. Sharsheret's Genetic Counselor Danielle Singer, MS, CGC and Dr. Kristin Zorn, Director of the Division of Gynecologic Oncology, UAMS College of Medicine and National Ovarian Cancer Coalition Medical Scientific Advisory Board member discuss the basics of BRCA, Lynch Syndrome, the genetic counseling process, and the psychosocial implications of genetic testing for individuals and families. They also address ovarian cancer genetic screening treatment options and what you should be asking your physician. Sharsheret, Hebrew for "chain", supports young Jewish women and families facing breast cancer at every stage—before, during, and after diagnosis. They help women and families connect to our community in the way that feels most comfortable, taking into consideration their stage of life, diagnosis, or treatment, as well as their connection to Judaism. They also provide educational resources, offer specialized support to those facing ovarian cancer or at high risk of developing cancer, and create programs for women and families to improve their quality of life. All Sharsheret's programs are open to all women and men. More information may be found at www.sharsheret.org
Просмотров: 448 NOCCNational
B.C. Cancer Agency's Dr. Stephen Chia comments on mastectomy A Canadian breast cancer specialist wants people to learn from actress Angelina Jolie's experience and seek genetic testing. Jolie wrote an op-ed piece that appeared in the New York Times Tuesday called "My Medical Choice" about her decision to have a preventive double mastectomy after her mother died of cancer at age 56 and tests for the "faulty" BRCA 1 mutation revealed she had a high likelihood of developing breast and ovarian cancer. Below we answer some questions about the procedure: Is the testing covered in Canada? Provincial health plans cover the cost of BRCA1 and BRCA2 mutation testing in patients that meet criteria, such as a diagnosis of breast or ovarian cancer in a family history. "Only 10 per cent of the women with a mutation have been identified, so if we can use this to increase the number to 20 or 25 per cent I think that would be an opportunity," said Dr. Steven Narod, director of the Familial Breast Cancer Research Unit at Women's College Research Institute in Toronto. The main factors that keep women from getting the blood test for the mutation are that they don't know that tests are available and doctors don't regularly ask about family medical history, Narod said. "We know scientifically that you are just as likely to get a mutation from your dad as from your mom," Narod said. "The fact is, we've missed all the women who inherited the mutation from their father, because they didn't come to the attention of the geneticist because they didn't have the extended family history of breast cancer." What does the procedure involve? In double mastectomies, surgeons typically remove as much breast tissue as possible. In Jolie's case, because she was having a reconstruction done shortly afterward, the doctors preserved the skin covering her breasts, inserting "fillers" where the breast tissue would have been, to keep the skin elastic. "Basically, you have to go through a full mastectomy, get tissue expanders put in, go through a full year of expansion to create a pocket in between your rib cage and your pectoral muscles so they have somewhere to put the implant," said Theresa Quick of Toronto, who underwent a preventive double mastectomy last year. Both of Quick's grandmothers died of breast cancer. Her mother also had breast cancer, carried BRCA 1 and died at 52 of ovarian cancer. Women share stories of life after a double mastectomy Ottawa woman tattoos chest after double mastectomy Kathy Bates goes public with double mastectomy decision For those who test positive and choose to have a preventive mastectomy, the procedure and reconstructive surgery are paid for by provincial plans. Dr. William Foulkes, a cancer geneticist at McGill University and Montreal's Jewish General Hospital, said Jolie's announcement goes a long way to demystifying the surgical experience. Foulkes is concerned about people rushing out for genetic testing. "If your risk of having a mutation is, say, one per cent and the test costs $1,600, is that a good use of health-care dollars?" said Foulkes. "I think our job is to make the test cheaper." How many women have this faulty gene? Angelina Jolie 1 of 12 Only a small percentage of women have this same faulty gene, or a similar mutated version of a related gene, BRCA2. While breast cancer is the most common cancer in women over 20, five to 10 per cent of all cases are hereditary. These mutations are most commonly found in women of eastern European Jewish descent; one study found 2.3 per cent of women in that group had the mutations — about five times higher than in the general population. Other ethnic groups, including the Norwegian, Dutch and Icelandic people, also have slightly higher rates of these mutations. In Jolie's case, Narod speculated she may have inherited a mutation specific to French-Canadians that represents 80 per cent of the BRCA1 mutations in Quebec. How do these genes increase a woman's risk of breast cancer? The average woman has a 12 per cent risk of developing breast cancer sometime during her life. In comparison, women who have inherited a faulty version of a breast cancer gene are about five times more likely to get breast cancer. "Age of diagnosis of cancer is a really important predictor of whether the cancer is hereditary," said Rochelle Demsky, a genetic counsellor at Princess Margaret Cancer Centre in Toronto. What other preventive options exist? Narod said women at high risk from mutations are offered screening tests such as MRIs to detect cancer earlier. Drugs such as tamoxifen and raloxifene can also be given preventatively for women without breast cancer who carry the mutations although clinical trials into their long-term use are ongoing. Another preventive surgery, bilateral prophylactic oophorectomy — removing both ovaries and Fallopian tubes — is also an option.
Просмотров: 2957 TipsHealth
BRCA1 and BRCA2 are tumor suppressor genes that have an essential role in both DNA repair and cell cycle control systems. Germline BRCA1 and BRCA2 mutations are implicated in 25-50% of hereditary breast cancer cases. Learn more at: http://www.ambrygen.com/tests/brca1-and-brca2
Просмотров: 1768 Ambry Genetics
Angelina Jolie recently announced she tested positive for the BRCA-1 genetic mutation putting her at an increased risk for developing breast and ovarian cancer. Given this information, she made the decision to have a preventive double mastectomy. Her announcement has raised a heightened level of awareness about genetic mutations and preventative mastectomies and has been the topic of much discussion for the last two days. During this Google+ Hangout On-Air featuring a panel of experts and physicians on the medical staff at Baylor Health Care System hospitals, we answered a series of commonly asked questions about preventive mastectomies, genetic testing and the impact Angelina Jolie 's announcement will have on this trend. For more information about genetic testing for breast cancer, visit http://www.baylorhealth.edu/SpecialtiesServices/Pages/PrecisionMedicine.aspx This video is a part of the Baylor Scott & White Health "Healthy Hangout" series, where our panel of experts will discuss prevalent health topics, to provide you with the resources and information you need to make proactive decisions about your health.
Просмотров: 884 Baylor Scott & White Health
Yale's Director of Cancer Genetic Screening, Counseling & Testing, Ellen Matloff, joins OneWorld Progressive Institute's, N'Zinga Shäni, to define exactly what genetic screening, counseling and testing means and discuss the important implications. The age of diagnosis is very important, and whether it is Colorectal, Breast, Ovarian, etc.
Просмотров: 234 oneworldpi
As Dr. Mike Janicek explains in this video, sometimes a negative BRCA test for breast cancer is more difficult to counsel than a positive BRCA gene test. Lisa Schneider-Cipriano, for example, had a negative BRCA test but had a family history of breast cancer and ended up getting it herself. Watch this video to learn more. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/subscription_center?add_user=drjayharness VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS http://www.breastcanceranswers.com/video-categories/# SUBMIT A QUESTION http://www.breastcanceranswers.com/ask DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/ CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers?ref=hl Twitter: https://twitter.com/BreastCancerDr ______ Disclaimer: This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
Просмотров: 2794 Breast Cancer Answers®
Check out: aclu.org/genepatents Association for Molecular Pathology v. Myriad Genetics: This case involves a challenge to patents on two human genes known as BRCA1 and BRCA2. Mutations in those genes correlate with an increased risk of breast and ovarian cancer. On behalf of a large coalition of research scientists, patients, and patient advocacy groups, we have argued that human genes cannot be patented because they are classic products of nature. The case goes to the U.S. Supreme Court on April 15th. Find out more: aclu.org/genepatents Transcript: - Not many people who have cancer, their cancer could have been prevented. I have advanced stage ovarian cancer that could have been prevented. My name's Kathleen Maxian. My prognosis is that I have a 20% chance of living for five years. I remember the day that I got the call from my gynecologist. He said to me, "Oh, honey, you have ovarian cancer." After my surgery... Dr. duPont says to me, "Kathleen, after your surgery, your mother mentioned that your sister had breast cancer." And I said, "Oh, yes, but our cancer isn't genetic, because she had the testing, and the testing was negative." And I will never forget that she put her head down and she looked back up at me and she said, "We'd like to see a copy of the tests." - BRCA1 and BRCA2 are two genes that when mutated or changed increase the likelihood that women will develop breast and ovarian cancer. The genes were found using many different researchers, but they were patented by Myriad Genetics in the mid-1990s. Many laboratories in the United States were offering BRCA1 and 2 testing. When Myriad Genetics began cracking down and closing labs, no one else could offer the test. When a patent comes to mind, you think of a new invention. There was nothing new about what they were doing. But the comprehensive testing that they've developed looks for mutations within BRCA1 and 2. - I believed that the test that my sister got was a comprehensive test. This is the gold standard of genetic testing, it's only done at this one lab, and it comes back, and it's negative. And everybody in our family kind of goes, "Whew," you know? - But what we learned in the late 1990s, early 2000s, is that "comprehensive BRAC analysis" was missing mutations in some families. I contacted Myriad Genetics and asked them if we could offer a test for our patients who tested negative, but in whom we really suspected we were missing something, and we were told, "Absolutely not. It's a patent violation." And Myriad, after many years, developed BART testing to hopefully pick up those patients. Kathleen's sister didn't meet the high risk criteria to be included in Myriad's BART analysis for free. - And her genetic counselor said, "Okay, because your sister has ovarian cancer now, you meet the criteria." Her genetic counselor tested her, and the result was positive. - Unfortunately, in that family, the mutation fell in the BART region. - I'm like, "What? "What is going-- What do you mean? What do you mean it's positive?" Like, and if she had had that two years ago, it would have been a no-brainer for me to have a hysterectomy. - I think that this patent, which has jacked up the prices and made testing more difficult in many circumstances, may be preventing hundreds or even thousands and thousands of people from learning that they're at high risk for these terrible diseases. - I feel like this-- that cancer has taken over my life. And...and... I live in fear every single day. I would love for them to say, "This is bigger than us. "Let's get rid of the patent. Let's let other people get involved in this." [gentle acoustic music]
Просмотров: 45380 ACLU
Dr. Anagnost, an oncologist with Cape Fear Cancer Specialists - NHRMC Physician Group, talks about the purpose of the genetic testing for breast cancer and who should consider it.
Просмотров: 218 New Hanover Regional Medical Center
When Leslie Anderson was 18 she lost her mother to breast cancer. Years later, her sister was diagnosed with ovarian cancer. It left Anderson wondering whether all the women in her family were susceptible. "That was just an absolute sign that we all needed to be tested," says Anderson. It meant playing cancer detective, something that wasn't an option when her mom was diagnosed. "She passed in 1980 and the BRCA gene wasn't identified until 90's and genetic testing wasn't really available until the late 90's," says Anderson. "We do a family tree and determine a criterium for genetic testing," says Mary Ann Orlang, with Lee Memorial Health System. Orlang is a genetic counselor who facilitates testing at the Regional Cancer Center. "This one they actually have to do it in front of me because it is DNA testing. It just authenticates that it is their DNA," says Orlang. The most frequent test looks for BRCA, also known as the breast cancer gene. "The analysis determines a women's risk for genetically-linked breast cancer or hereditary breast cancer. Not only breast cancer but also ovarian cancer," says Orlang. From this location, they provide counseling and gene testing for a variety of cancers, not just breast. Others include forms of gynecological, gastrointestinal, endocrine and melanoma skin cancer. Results help patients assess their risk. "Knowing your risk gives you the power to do something about it," says Orlang. Anderson and two of her three sisters tested positive for BRCA 1. She underwent a double mastectomy and had her ovaries removed to greatly cut her cancer risk. "It's just amazing they can come up with this information and break down on a DNA genetic level to find out what you're at a risk for," says Anderson. Looking into their genes, may give people the chance to break a family tradition. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 25 Lee Health
CancerNextTM is a next generation (next-gen) sequencing panel that simultaneously analyzes 28 genes that contribute to increased risk for breast, colon, ovarian, uterine and other cancers. Learn more: http://www.ambrygen.com/tests/cancernext/
Просмотров: 1865 Ambry Genetics